Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis?

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 1009-1012

  Fowler, Jack F ^a   Toma Dasu, Iuliana ^b   Dasu, Alexandru ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alapha beta; LQ model; Prostate cancer; Radiation therapy

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; HUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; REVIEW;

DOSE FRACTIONATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK;

EID: 84875894190     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Brenner DJ and Hall EJ: Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43: 1095-1101, 1999.
2. Proust-Lima C, Taylor JM, Secher S, Sandler H, Kestin L, Pickles T, Bae K, Allison R and Williams S: Confirmation of a low α/β ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics. Int J Radiat Oncol Biol Phys 79: 195-201, 2011.
3. Miralbell R, Roberts SA, Zubizarreta E and Hendry JH: Dosefractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of patients in seven international institutional datasets: α/β=1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys 82: e17-e24, 2012.
4. Dasu A and Toma-Dasu I: Prostate alpha/beta revisited - an analysis of clinical results from 14168 patients. Acta Oncol 51: 963-974, 2012.
5. Barendsen GW: Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 8: 1981-1997, 1982.
6. Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62: 679-694, 1989.
7. Williams SG, Taylor JM, Liu N, Tra Y, Duchesne GM, Kestin LL, Martinez A, Pratt GR and Sandler H: Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer. Int J Radiat Oncol Biol Phys 68: 24-33, 2007.
8. Miralbell R, Roberts SA, Zubizarreta E and Hendry JH: Dosefractionation sensitivity of low/middle/high-risk prostate cancer deduced from seven international primary institutional datasets (Abstract). Int J Radiat Oncol Biol Phys 75: S81, 2009.
9. Dasu A: Is the α/β value for prostate tumours low enough to be safely used in clinical trials? Clin Oncol 19: 289-301, 2007.
10. Dasu A, Toma-Dasu I and Fowler JF: Should single or distributed parameters be used to explain the steepness of tumour control probability curves? Phys Med Biol 48: 387-397, 2003.
11. Vogelius IR and Bentzen SM: Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news? Int J Radiat Oncol Biol Phys 85: 89-94, 2013.
12. Fowler J and King CR: Don't squeeze hypofractionated schedules into too-short overall times. Int J Radiat Oncol Biol Phys 75: 323-325, 2009.
13. Dasu A: Radiobiology of prostate cancer. In: Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Ponsky LE, Fuller DB, Meier RM and Ma C-MC (eds.). Berlin, Springer, pp. 79-101, 2012.